This session will provide a comprehensive overview of atopic dermatitis, beginning with its underlying pathophysiology and disease mechanisms. Faculty will review the clinical manifestations of atopic dermatitis, including important considerations in skin of color, and discuss tools for evaluating disease severity and overall impact on patients and their families. Evidence-based management strategies will be introduced, with a focus on topical corticosteroids and calcineurin inhibitors commonly used in primary care. The program will also explore treatment options beyond the primary care setting, including advanced therapies and emerging agents currently being studied in randomized controlled trials.

Innovation Theater sponsored by Inspire Medical Systems Innovation Theaters are informational sessions designed to complement your educational experience by further enhancing your knowledge and confidence of disease states or products. No CE credits are offered at these programs.

This session provides attendees with an evidence-based update on breast, cervical, and colorectal cancer screening. Participants will review current guideline recommendations, including starting ages, screening intervals, and risk-based modifications, while examining areas of controversy and evolving practice. The session will emphasize practical application through case-based discussion and strategies for shared decision-making. Attendees will also explore workflow approaches to improve screening uptake, reduce disparities, and ensure appropriate follow-up in the primary care setting.

Innovation Theater sponsored by Corcept Therapeautics Incorporated Innovation Theaters are informational sessions designed to complement your educational experience by further enhancing your knowledge and confidence of disease states or products. No CE credits are offered at these programs.

Inflammatory bowel disease (IBD) is a chronic, increasingly prevalent condition that primary care clinicians encounter throughout the patient journey. This session will review the epidemiology and clinical burden of ulcerative colitis, Crohn’s disease, and microscopic colitis, while highlighting the critical role of primary care in timely diagnosis, initial evaluation, and collaborative management with gastroenterology specialists. Participants will learn to recognize key signs and symptoms of IBD, distinguish IBD from irritable bowel syndrome and other common gastrointestinal disorders, and implement an appropriate diagnostic workup in the primary care setting. The program will also examine current treatment options, medication safety considerations, and best practices for preventive care, vaccination, and ongoing monitoring to optimize outcomes for patients living with IBD.

Innovation Theater sponsored by Ironwood Pharmaceuticals Innovation Theaters are informational sessions designed to complement your educational experience by further enhancing your knowledge and confidence of disease states or products. No CE credits are offered at these programs.

Low back pain is one of the most common and costly conditions encountered in primary care, yet management decisions often vary widely. This session provides a practical, evidence-based framework for evaluating and treating both acute and chronic back pain in the outpatient setting. Participants will review red flag identification, appropriate imaging use, first-line pharmacologic and nonpharmacologic therapies, and strategies to support functional recovery. Emphasis will be placed on patient communication, risk stratification, and safe prescribing practices.

Polypharmacy is increasingly common in primary care, particularly among older adults and patients with multiple chronic conditions. While many medications are evidence-based, cumulative prescribing can increase the risk of adverse drug events, falls, hospitalizations, and reduced quality of life. This session will provide practical, evidence-informed strategies to identify high-risk patients, conduct efficient medication reviews, and implement safe deprescribing in everyday practice. Through case-based discussion and actionable tools, participants will gain skills to optimize medication regimens while aligning treatment decisions with patient goals of care.

This session will provide primary care clinicians with the latest evidence-based updates in the management of hypertension. Faculty will review recent guideline changes, emerging pharmacologic therapies, and practical strategies for optimizing blood pressure control in diverse patient populations. Emphasis will be placed on individualized treatment selection, improving medication adherence, and addressing common comorbidities encountered in everyday practice.

Innovation Theaters are informational sessions designed to complement your educational experience by further enhancing your knowledge and confidence of disease states or products. No CE credits are offered at these programs.

Supported by an educational grant from Johnson & Johnson.

Innovation Theaters are informational sessions designed to complement your educational experience by further enhancing your knowledge and confidence of disease states or products. No CE credits are offered at these programs.

This session provides attendees with an evidence-based update on breast, cervical, and colorectal cancer screening. Participants will review current guideline recommendations, including starting ages, screening intervals, and risk-based modifications, while examining areas of controversy and evolving practice. The session will emphasize practical application through case-based discussion and strategies for shared decision-making. Attendees will also explore workflow approaches to improve screening uptake, reduce disparities, and ensure appropriate follow-up in the primary care setting.

Innovation Theaters are informational sessions designed to complement your educational experience by further enhancing your knowledge and confidence of disease states or products. No CE credits are offered at these programs.

Metabolic syndrome is a common yet often underrecognized driver of cardiovascular disease, type 2 diabetes, and other chronic conditions encountered daily in primary care. This session will provide clinicians with a practical, evidence-based approach to identifying metabolic syndrome using current diagnostic criteria and assessing overall cardiometabolic risk. Participants will review effective lifestyle and pharmacologic management strategies, including emerging therapies, and learn how to prioritize treatment of individual risk components. Through case-based discussion, attendees will gain actionable tools to implement team-based, patient-centered interventions that improve long-term outcomes in the primary care setting.

This session will provide primary care clinicians with a comprehensive update on 2026 immunization recommendations for adults, children, and adolescents with focused guidance for special populations. Practical strategies for implementation in primary care will be emphasized, including coadministration best practices, standing orders, documentation and registry updates, billing considerations, and approaches to reducing missed vaccination opportunities. Participants will also gain evidence-based tools to address vaccine hesitancy and optimize immunization delivery within their clinical workflows.

This session will equip viewers with practical tools to recognize, evaluate, and manage mild cognitive impairment (MCI) in everyday practice. Through real-world cases, participants will review diagnostic criteria, workflow-friendly cognitive screening strategies, documentation best practices, and the critical role of caregiver input. The program will also explore emerging Alzheimer’s research, including disease-modifying therapies, anti-amyloid monoclonal antibodies, biomarker advances, and the implications of treatment eligibility.

Anxiety disorders, including generalized anxiety disorder, panic disorder, and social anxiety disorder, are common in primary care but often go underdiagnosed. This session will provide high-yield screening tools, evidence-based treatment strategies, and key considerations for long-term management. Faculty will also discuss benzodiazepine risks, alternative medication options, and when to incorporate therapy-based interventions.

Innovation Theaters are informational sessions designed to complement your educational experience by further enhancing your knowledge and confidence of disease states or products. No CE credits are offered at these programs.

This activity is supported by an educational grant from Lilly. Alcohol use disorder (AUD) is a prevalent and often undertreated condition that exists along a spectrum of severity, yet stigma and inconsistent assessment continue to limit optimal care. This session will review the medical model of AUD and its role in improving recognition, reducing stigma, and guiding evidence-based treatment. Participants will gain practical skills in implementing validated screening tools and assessment strategies to support accurate diagnosis in diverse clinical settings. The session will also evaluate current behavioral and pharmacologic treatments, including best practices for medication-assisted treatment (MAT) selection, initiation, and maintenance. Finally, attendees will explore patient-centered, collaborative approaches to overcoming common barriers to effective AUD management. Clinicians will leave equipped with actionable strategies to enhance outcomes for patients across the AUD severity spectrum.

Innovation Theaters are informational sessions designed to complement your educational experience by further enhancing your knowledge and confidence of disease states or products. No CE credits are offered at these programs.

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

As awareness of adult ADHD grows, primary care clinicians are increasingly responsible for diagnosing and managing the condition. This session will provide practical guidance on high-yield screening tools, distinguishing ADHD from look-alike conditions, and choosing the most effective pharmacologic and behavioral treatments. Faculty will also address regulatory updates affecting stimulant prescribing and telemedicine access.